Guidelines for the use of CGM in Australian Schools April 2021
Guidelines for the use of Continuous Glucose Monitoring (CGM) in Australian Schools September 2021
All young people living with Type 1 Diabetes (T1D) are entitled to the highest standard of individualised, person centred care. (1) CGM is a management tool that is authorised and prescribed by the treating medical team and consented by the parent to assist the student to stay safe and assist with keeping blood glucose levels in target range. Education providers are obliged to fulfil the prescribed treatment for the student with T1D in response to the individual needs. Education providers implement the specific, individual requirements of the prescribed treatment in consultation, and agreement, with the parent. (1)
This document directly references the International Society of Pediatric and Adolescent Diabetes (ISPAD) Position Statement on Diabetes in Schools (2) and the American Diabetes Association Guidelines for the use of a Continuous Glucose Monitor (CGM) and Sensor in the School Setting (3) and has contextualised the application of these documents for Australia.
The purpose of this statement is to provide general information about the use of CGM in the Australian school setting. Generic and standardised guidance for T1D treatments and/or implementation requirements is inappropriate. (3) Specific questions unique to individual students should be directed to the parents and treating medical team. (4)